Antiobesity Meds May Curb Weight Regain After RYGB
FRIDAY, May 22, 2020 -- The antiobesity medications (AOMs) phentermine and topiramate may help mitigate weight regain (WR) after Roux-en-Y gastric bypass (RYGB) surgery, according to a study published online May 22 in Obesity.
Nawfal W. Istfan, M.D., Ph.D., from Boston University, and colleagues reviewed electronic medical records of 1,196 patients who underwent RYGB between 2004 and 2015. By comparing each patient's weight during subsequent postoperative office visits with nadir weight (lowest after RYGB), the researchers evaluated WR while taking into consideration the interval during which WR occurred. Patients who were prescribed AOMs and came to follow-up visits were classified as adherent users, while nonadherent patients were those who missed their follow-up visits.
Of the 760 patients included in the cohort, 46.1 percent were documented AOM users: 34.0, 21.1, and 44.0 percent were prescribed phentermine alone, topiramate alone, and a combination of phentermine and topiramate, respectively. The researchers found that use of phentermine and topiramate, individually or in combination, was associated with significant reductions in WR after RYGB in three statistical models.
"Phentermine and topiramate could play a role in the management of weight relapse after RYGB," the authors write. "However, the full potential of these agents and newer AOMs to counter weight recidivism and prevent the recurrence of obesity-related comorbidities needs to be further explored in prospective clinical trials."
One author disclosed financial ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.
Posted: May 2020
Read this next
Bariatric Surgery Cuts Cancer Risk With Obesity + Liver Disease
FRIDAY, April 9, 2021 -- Bariatric surgery is associated with significant reductions in the risks for any cancer and obesity-related cancer in nonalcoholic fatty liver disease...
Diet, Exercise Intervention Explored in Children With B-ALL
THURSDAY, April 8, 2021 -- For children with B-cell acute lymphoblastic leukemia (B-ALL), a diet and exercise intervention might improve disease response, according to a study...
Shelter-in-Place Orders Tied to Weight Gain
TUESDAY, April 6, 2021 -- Shelter-in-place orders were associated with consistent weight gain, according to a research letter published online March 22 in JAMA Network...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.